NORCET 5 mains: Which classification of drugs is contraindicated for the client with hypertrophic cardiomyopathy (HCM)?

NORCET 5 mains

Pharmacology

Medium

Appeared in: NORCET 5 mains

Explanation

Hypertrophic cardiomyopathy (HCM) often involves a dynamic obstruction of the left ventricular outflow tract (LVOT) caused by the thickened heart muscle.
Positive inotropes are drugs that increase the force of myocardial contraction (contractility).
By increasing contractility, these drugs cause the thickened muscle to obstruct the outflow tract more severely, which can lead to a dangerous decrease in cardiac output and increased risk of syncope or sudden death.
Therefore, positive inotropes directly worsen the primary pathophysiological problem in obstructive HCM and are contraindicated.

Option B: While vasodilators (especially those that reduce preload, like nitrates) are used with extreme caution and can be harmful in HCM by worsening the outflow gradient, they are not as universally and fundamentally contraindicated as positive inotropes. Their primary effect is on blood vessels, not directly on heart muscle contractility.
Option C: Diuretics are used cautiously in HCM to manage symptoms of fluid overload (e.g., dyspnea). While excessive use can reduce preload and worsen the obstruction, they are not absolutely contraindicated and are often part of the management plan.
Option D: Antidysrhythmics are frequently necessary for clients with HCM. Arrhythmias, particularly atrial fibrillation, are common and poorly tolerated. Drugs like beta-blockers and calcium channel blockers are used to control rhythm and rate, and they have the added benefit of being negative inotropes, which helps reduce the obstruction.

Clinical Relevance

Nursing practice connection: This is primarily an exam-oriented knowledge point with limited direct bedside application, so retain Pharmacological contraindications in hypertrophic cardiomyopathy (HCM) as background academic context rather than a clinical decision trigger.
A nurse must be able to identify drugs that are unsafe for patients with specific cardiac conditions. Administering a positive inotrope to a patient with obstructive HCM is a critical medication error that can have fatal consequences.
Patient education is vital. The nurse should teach the patient and family about the importance of medication adherence and which over-the-counter or prescribed medications to avoid.
What if? If a patient with HCM develops cardiogenic shock due to a separate issue (like a massive MI), the use of inotropes becomes a high-risk, complex decision for a critical care team, weighing the need for circulatory support against the risk of worsening the obstruction. This is a 'rescue' scenario, not standard therapy.

How to Approach the Question

First, identify the core pathophysiology of the disease mentioned: Hypertrophic Cardiomyopathy (HCM) involves a thickened heart muscle that can obstruct blood flow.
Next, analyze the question's keyword: 'contraindicated.' This means you are looking for a drug class that is absolutely forbidden because it would cause harm.
Consider the mechanism of action for each drug class provided in the options.
Evaluate how each mechanism would interact with the pathophysiology of HCM. Ask yourself: 'Would this drug's effect help, have no effect, or worsen the obstruction?'
A drug that increases contractility (positive inotrope) would logically make a muscular obstruction worse. Compare this direct harm to the risks of the other drug classes (which are often related to fluid/pressure changes and require caution, but aren't a direct worsening of the core problem).
Select the drug class that poses the most direct and fundamental danger based on its mechanism of action.

Concept Tested & Keywords

Concept Tested: Pharmacological contraindications in hypertrophic cardiomyopathy (HCM)
Stem keywords: hypertrophic cardiomyopathy, HCM, contraindicated, drugs
Lead-in keywords: Which
Negative lead-in flag: false

Qe_ymK6b-Mg5Sh0t4kAMk1

E6 Pharmacology Katzung 16e pp. 339-341, 329-331

E6 Pharmacology Nursing Lilley 11e Part 2 p. 69-71